2025 HCPCS Code C9792
Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)
TAGS: symptomatic imaging class association investigational intra procedure nonblinded sinus procedurally jugular exemption performed implantation optimal device using heart necessary placement blinded anesthesia transcatheter coronary shunt atrial approved general| Short Description | Blind/nonblind trans atrial |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | October 01, 2023 |
| HCPCS Action Effective Date | October 01, 2023 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9121 - Injection, argatroban
- C9122 - Mometasone furoate (sinuva)
- C9132 - Kcentra, per i.u.
- C9133 - Factor ix recombinant
- C9134 - Factor xiii a-subunit recomb
- C9135 - Factor ix (alprolix)
- C9136 - Factor viii (eloctate)
- C9137 - Adynovate factor viii recom
- C9138 - Nuwiq factor viii recomb
- C9139 - Idelvion, 1 i.u.
- C9140 - Afstyla factor viii recomb
- C9141 - Factor viii pegylated-aucl
- C9142 - Inj, alymsys, 10 mg
- C9143 - Cocaine hcl nasal (numbrino)
- C9144 - Inj, bupivacaine (posimir)
- C9145 - Inj, aponvie, 1 mg
- C9146 - Inj, elahere, 1 mg
- C9147 - Inj, tremelimumab-actl, 1 mg
- C9148 - Inj, teclistamab-cqyv, 0.5mg
- C9149 - Inj, teplizumab-mzwv, 5 mcg
